<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0410538" disease_type="Disease or Syndrome" abbrv="PSACH">Pseudoachondroplasia</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e>) is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> disease that mainly affects cartilage, resulting in <z:hpo ids='HP_0002652'>skeletal dysplasias</z:hpo> and early <z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0002758'>osteoarthritis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> is caused by mutations in the cartilage oligomeric matrix protein (COMP) gene </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> chondrocytes accumulate unique COMP-containing lamellar structures in an expanded rough endoplasmic reticulum (rER) </plain></SENT>
<SENT sid="3" pm="."><plain>Although COMP is also present in tendon extracellular matrix (ECM), it does not accumulate in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> tendon cells, suggesting the disease involves a chondrocyte-specific trafficking problem </plain></SENT>
<SENT sid="4" pm="."><plain>To investigate putative cell-specific trafficking differences, we generated a cell culture model utilizing expression of the common DeltaD469 COMP mutation </plain></SENT>
<SENT sid="5" pm="."><plain>In rat <z:hpo ids='HP_0006765'>chondrosarcoma</z:hpo> (RCS) cells, we find delayed secretion and ER accumulation of DeltaD469 COMP, paralleling the altered trafficking defect in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> chondrocytes </plain></SENT>
<SENT sid="6" pm="."><plain>Non-chondrocytic COS-1 cells, in contrast, efficiently trafficked and secreted both mutant and <z:mp ids='MP_0002169'>wild-type</z:mp> COMP </plain></SENT>
<SENT sid="7" pm="."><plain>In chondrocytic cells, expression of DeltaD469 COMP led to ER accumulation of type IX collagen, but did not affect aggrecan trafficking </plain></SENT>
<SENT sid="8" pm="."><plain>Endogenous rat COMP accumulated in the ER along with expressed DeltaD469 COMP in a stably expressing RCS clone, consistent with the dominant negative effect of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>When these stably expressing cells were cultured to promote ECM deposition, the small amount of secreted mutant COMP disrupted assembly of the <z:mpath ids='MPATH_458'>normal</z:mpath> fibrillar meshwork and caused irregular aggregates of COMP and type IX collagen to form </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, in a new model that reflects the cellular pathology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e>, we establish trafficking differences for mutant COMP in chondrocytic and non-chondrocytic cells and demonstrate that mutant COMP interferes with assembly of a <z:mpath ids='MPATH_458'>normal</z:mpath> ECM </plain></SENT>
</text></document>